Renin-angiotensin system blockade is effective in reducing proteinuria of patients with progressive nephropathy caused by MYH9 mutations (Fechtner-Epstein syndrome).
Pecci
Alessandro
A
Department of Internal Medicine, University of Pavia, IRCCS Policlinico San Matteo Foundation, Piazzale Golgi 2, 27100 Pavia, Italy. alessandro.pecci@unipv.it
Granata
Antonio
A
Fiore
Carmelo E
CE
Balduini
Carlo L
CL
D000293:Adolescent; D000328:Adult; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D002386:Cataract / Q000235:genetics; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000235:genetics; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000235:genetics*; D019808:Losartan / Q000627:therapeutic use; D008297:Male; D020409:Molecular Motor Proteins / Q000235:genetics*; D009154:Mutation; D018995:Myosin Heavy Chains / Q000235:genetics*; D011507:Proteinuria / Q000188:drug therapy* / Q000235:genetics*; D017257:Ramipril / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects*; D013577:Syndrome; D000077333:Telmisartan; D013921:Thrombocytopenia / Q000235:genetics
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; C103814:MYH9 protein, human; D020409:Molecular Motor Proteins; D018995:Myosin Heavy Chains; D019808:Losartan; D017257:Ramipril; D000077333:Telmisartan